Was unsere Experten publizieren
annals-of-oncology-2008_1 annals-of-oncology-2008_2
european-journal-of-gastroenterology-hepatology
Immuncheckpoint-Blockade-bei-gastrointestinalen-Tumoren
Cigarette Smoking as a risk factor for development and mortality from hepatocellular carcinoma
Early stage hepatocellular carcinoma in the elderly
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors
Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma
Systematic review of haemorrhage and rupture of hepatocellular adenomas
Treatment-associated Fatigue in Cancer Patients Treated with Immune Checkpoint Inhibitors
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors Systematic review of haemorrhage and rupture of hepatocellular adenomas
Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors
Early stage hepatocellular carcinoma in the elderly
Cigarette Smoking as a risk factor for development and mortality from hepatocellular carcinomatreatment-associated-fatigue-in-cancer-patients-treated-with-immune-checkpoint-inhibitors-pdf
the-role-of-the-tumor-endothelium-in-leukocyte-recruitment-in-pancreatic-cancer-pdf
serum-levels-of-chemokines-ccl4-and-ccl5-in-cirrhotic-patients-pdf
prognostic-and-predictive-value-of-immunological-parameters-pdf
hypothermie-ante-situm-resection-in-tumors-of-the-hepatocaval-confluence-pdf
influence-of-interferon-alpha-combined-with-chemo-radio-therapy-pdf
Inhalt demnächst verfügbar
Inhalt demnächst verfügbar
xxxxxxxxxx
Early stage hepatocellular carcinoma in the elderly
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors
Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma
Treatment-associated Fatigue in Cancer Patients Treated with Immune Checkpoint Inhibitors
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors
Treatment-associated Fatigue in Cancer Patients Treated with Immune Checkpoint Inhibitors
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint Inhibitors
Early stage hepatocellular carcinoma in the elderly
